Zobrazeno 1 - 3
of 3
pro vyhledávání: '"André L. B. Barros"'
Autor:
Larissa D. Coelho, Mirna M. D. Souza, Geovanni D. Cassali, Raphaela A. Silva, Maria J. N. Paiva, André L. B. Barros, Eliane M. Teixeira, Josianne N. Silveira, Paulo M. Z. Coelho, Marta M. G. Aguiar, Mônica C. Oliveira
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 904 (2023)
Emetic tartar (ET), was used in the treatment of leishmaniasis but its use was discontinued due to its low therapeutic index. Liposomes have been shown to be a promising strategy for delivery of bioactive substances in the region of interest, in orde
Externí odkaz:
https://doaj.org/article/aa862f263bf042b1be18605bee864be3
Autor:
Renata S. Fernandes, Raquel Gregório Arribada, Juliana O. Silva, Armando Silva-Cunha, Danyelle M. Townsend, Lucas A. M. Ferreira, André L. B. Barros
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2394 (2022)
Doxorubicin (DOX) is an antineoplastic agent clinically employed for treating breast cancer patients. Despite its effectiveness, its inherent adverse toxic side effects often limit its clinical application. To overcome these drawbacks, lipid–polyme
Externí odkaz:
https://doaj.org/article/0277d40a187a4344adceea045ab77aae
Autor:
Darline B. dos Santos, Janaina A. Lemos, Sued E. M. Miranda, Leonardo D. Di Filippo, Jonatas L. Duarte, Lucas A. M. Ferreira, Andre L. B. Barros, Anna E. M. F. M. Oliveira
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2339 (2022)
Leishmania is a trypanosomatid that causes leishmaniasis. It is transmitted to vertebrate hosts during the blood meal of phlebotomine sandflies. The clinical manifestations of the disease are associated with several factors, such as the Leishmania sp
Externí odkaz:
https://doaj.org/article/9eb57b0840184a638d5a6921f6929c3e